EDGAR Filing Documents for 0001047469-15-002679

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001047469-15-002679

Filing Date

2015-03-25

Accepted

2015-03-25 06:05:10

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	a2223797z20-f.htm	20-F	1832794
2	EX-1.1	a2223797zex-1_1.htm	EX-1.1	376987
3	EX-2.2	a2223797zex-2_2.htm	EX-2.2	415097
4	EX-12.1	a2223797zex-12_1.htm	EX-12.1	10845
5	EX-12.2	a2223797zex-12_2.htm	EX-12.2	10835
6	EX-13.1	a2223797zex-13_1.htm	EX-13.1	6322
7	EX-13.2	a2223797zex-13_2.htm	EX-13.2	6110
	Complete submission text file	0001047469-15-002679.txt		2659954

Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100

Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242

Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)